top of page
4_edited.jpg
Products Covid

Respiratory Infection Testing Solutions

(CE-IVD & RUO)

Upper Respiratory Panel

Respiratory viruses are a common culprit behind acute infections impacting the upper respiratory tract, including the nose, sinuses, pharynx, and larynx. Furthermore, these viruses can trigger pneumonia, which can be severe and fatal, particularly among vulnerable groups like adults, children, and those with weakened immune systems. Addressing these challenges requires rapid and precise screening methods to manage these conditions effectively and curb transmission.

Given the overlapping symptoms caused by various pathogens, diagnosing infectious diseases based solely on symptoms poses difficulties. GeneFirst's syndromic approach is easy to use, allowing clinicians to conduct a comprehensive assessment for a wide array of potential pathogens in a single assay. This method delivers swift and thorough results, empowering clinicians to make informed treatment decisions promptly, ultimately improving patient outcomes and satisfaction.

 

The GeneFirst Multiplex Probe Amplification (MPA) technology enables real-time PCR detection of multiple targets within a closed-tube reaction.  This allows for high throughput testing of patients, supporting accurate and expedited disease management and the prevention of further spread.

Target Pathogen
Strain
Adenovirus
Types 1, 2, 4, 5, 6 and 7
Bocavirus
Type 1
Human Coronavirus (HCoV)
Strains 229E, OC43, NL63, and HKU1
Human para influenza virus
hPIV1, hPIV2, hPIV3 and hPIV4 (A and B)
Influenza A
Subtypes H1, H3, H5 and H7
Influenza B
Includes Victoria and Yamagata lineages
Metapneumovirus (MPV)
Subtypes A and B
Mycoplasma pneumoniae
All known strains
Respiratory Syncytial Virus (RSV)
Subtypes A and B
Rhinovirus
Species A, B and C
Sars-CoV-2
All known variants of concern

Catalogue number: RESP003

Kit size: 96 tests

Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control

 

The GeneFirst Upper Respiratory Panel is CE-IVD marked and is for professional use only.

Lower Respiratory Panel

Testing for lower respiratory diseases, particularly those causing pneumonia, is paramount for comprehensive patient care and public health management. Accurate diagnosis of the causative agent, whether it be bacteria or viruses is essential for guiding appropriate treatment strategies. By identifying the specific pathogen responsible for the infection, healthcare providers can prescribe targeted antimicrobial therapy, minimizing unnecessary antibiotic use and optimizing patient outcomes.

Additionally, prompt diagnosis through testing facilitates early initiation of supportive measures, such as supplemental oxygen or respiratory therapies, which are critical for managing severe cases of pneumonia. Beyond individual patient care, testing for lower respiratory diseases plays a crucial role in public health surveillance efforts. Monitoring the prevalence and distribution of pneumonia-causing pathogens allows for timely implementation of infection control measures and targeted vaccination campaigns, helping to prevent outbreaks and reduce the burden of disease on communities.

The GeneFirst Multiplex Probe Amplification (MPA) technology enables real-time PCR detection of multiple targets within a closed-tube reaction.  This allows for high throughput testing of patients, supporting accurate and expedited disease management and the prevention of further spread.

Target Pathogen
Strain
Bordetella pertussis
All known strains
Coxiella burnetii
All known strains
Haemophilus influenzae
All known strains
Legionella pneumophila
All known strains
Moraxella catarrhalis
All known strains
Mycoplasma pneumoniae
All known strains
Pneumocystis jirovecii
All known strains
Staphylococcus aureus
All known strains
Streptococcus pneumoniae
All known strains

Catalogue number: RESP005

Kit size: 96 tests

Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control

 

The GeneFirst Lower Respiratory Panel is CE-IVD marked and is for professional use only.

COVID-19 Testing Solutions

(CE-IVD & RUO)

Throughout the pandemic, GeneFirst Limited have been committed to being a proactive developer and supplier of RT-PCR COVID-19 kits, with the launch of our CE-IVD kits for the detection of SARS-CoV-2 and other commonly circulating viral pathogens. In addition to this, GeneFirst have recently launched a single closed-tube multiplex assay for the detection of currently circulating Variants of Concern, called the COVID-19 Variant Detection Kit.

RT-PCR COVID-19 Detection Kit

Product features

 

  • In vitro real-time PCR-based test for the detection of two targets (ORF1ab and N gene) of SARS-CoV-2 virus

  • Excellent sensitivity and specificity

  • Single closed-tube assay for ease of use

  • Fast results in under 1 hour 40 minutes

  • Contains appropriate controls for PCR reaction and sample integrity

Catalogue number: COVID-19

Kit size: 96 tests

Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control

 

The GeneFirst COVID 19 Detection Kit is CE-IVD marked and is for professional use only.

 

Click here to view the product flyer for more information.

RT-PCR COVID-19 Plus Detection Kit

​Product features

 

  • In vitro real-time triplex PCR-based test for the detection of SARS-CoV-2, Influenza A/B and Respiratory Syncytial Virus

  • Excellent sensitivity and specificity

  • Single closed-tube assay for ease of use

  • Fast results in under 1 hour 40 minutes

  • Contains appropriate controls for PCR reaction and sample integrity

Catalogue number: RESP002

Kit size: 96 tests

Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control

 

The GeneFirst COVID-19 Plus Detection Kit is CE-IVD marked for diagnostic use only.

Click here to view the product flyer for more information.

RT-PCR COVID-19 Variant Detection Kit

​Product features

  • In vitro real-time PCR-based test for the detection of six variants of concern/variants under investigation; B.1.1.7 (Kent), P.1 (Brazil), B.1.351 (South Africa), B.1.525 (Nigeria), B.1.526 (New York) and B.1.1.318

  • Excellent sensitivity and specificity

  • Single closed-tube assay for ease of use

  • Fast results in under 1 hour 20 minutes

  • Contains appropriate controls for PCR reaction and sample integrity

Catalogue number: RESP006

Kit size: 96 tests

Kit includes: Primers and Probes, Reverse Transcriptase, DNA Polymerase and Positive Control

The GeneFirst COVID-19 Variant Detection Kit is a Research Use Only assay designed to be used in aiding the triage and stratification of previously confirmed COVID-19 positive samples.

Click here to view the product flyer for more information.

bottom of page